Member Info for Mimillasa

To ask ‘why’ is never a wise question……

Well you’re the expert - enlighten us all….

DENBY 69 Hope you get out soon from this board given your negativity.
Its at 16.00 now so sell up and move on - as you stated.

Denby69 you need to assimilate what is written in the post

GSK will defy the usual divi rollercoaster ride this time around. Watch this climb over the near future.

Denby, do not allow the CEO to become an unhealthy obsession..... Refocus Man.

Chess pieces are being moved into a winning position... Top up and hold on for the thrilling ride...

Your post is extremely negative and you might be wise to move back from your described precipice... Breathe.... And buy some more Glaxo shares....

Excellent signs and progress being made in the development of this much required pharmacalogical intervention. Patience is a virtue challenged by the desire and drive to make sizeable profits as a shareholder. HOLD steady and you will be rewarded in due course.

Go to Synairgen's home page - follow the link there

Perhaps we should be careful not to be drawn in by the naysayers and negative posters here who have an interest in decamping the share together with their quest to drive down share price to make money on your share sell!
'The wise man speaks because he has something to say whilst the fool speaks when they need to say something"........

Lots of 'reverse psychology' chatter going on here folks - hold steady - do not sell - this share will springboard from here shortly....

Excellent News - GSK progressing ultimately towards delivering positive outcomes to controlling multi variant virus worldwide.

'Results from the Phase 3 study are expected in the first half of 2022 after which, subject to positive results and regulatory approval, the vaccine is expected to be supplied at scale worldwide through the COVAX facility'.

Share Price is going to defy the naysayers - get in whilst the going is good and enjoy the rewards and dividends

Always good to have more than one hypothesis...

Reply to Denby 69 STAY POSITIVE

...Or may buck the trend and go up; interesting news from US
overnight:

"AnaptysBio Inc. shares rose 10% to $27.72 after hours as a second approved indication for a GlaxoSmithKline PLC drug will result in a $20 million milestone payment. The U.S. Food and Drug Administration approved GSK's Jemperli for the treatment of adult patients with mismatch repair deficient recurrent or advanced solid tumors. Jemperli was generated by AnaptysBio and subsequently developed by Tesaro Inc., which GSK bought in early 2019.

Woo Hoo at last we have broken the £15 threshold!

Amazing how quiet this GSK board has become in light of very promising share price movement. All positive - let's keep it that way for a change.

"why" is not necessarily a wise question in these matters; there will be no truths.
DYOR and make your own decisions...

Stay positive then